DiaMedica Therapeutics

DMAC

Capitalización de mercado USD 520 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	MHP 1 Manatuck Hill Partners Westport, Connecticut	USD 564 k	+USD 16.5 k	+5,100	+2%
2	2 Granite Point Capital Management Boston, Massachusetts	USD 470 k	-USD 8.86 k	-2,740	-1%
3	3 Worth Venture Partners Fort Lee, New Jersey	USD 294 k	+USD 30 k	+9,287	+7%
4	4 Wexford Capital West Palm Beach, Florida	USD 184 k	-USD 1.01 M	-311,140	-78%
5	5 Vanguard Group Malvern, Pennsylvania	USD 166 k	+USD 151 k	+46,817	+137%
6	6 Millennium Management New York	USD 145 k	-USD 91.9 k	-28,421	-29%
7	7 BlackRock New York	USD 53 k	-USD 4.73 k	-1,463	-5%
8	8 Geode Capital Management Boston, Massachusetts	USD 31 k	+USD 49.8 k	+15,399	Nuevas
9	9 Stonepine Capital Management Bend, Oregon	USD 28 k	+USD 44.3 k	+13,705	Nuevas
10	10 Commonwealth Equity Services Waltham, Massachusetts	USD 27 k	+USD 42.9 k	+13,277	Nuevas
11	11 UBS Group Zurich, Switzerland	USD 5 k	+USD 336	+104	+5%
12	12 Royal Bank of Canada Toronto, Ontario, Canada	USD 5 k	+USD 860	+266	+14%
13	13 Patriot Financial Group Insurance Agency Westborough, Massachusetts	USD 4 k	–	–	–
14	14 Bank of Montreal Toronto, Ontario, Canada	USD 1 k	–	–	–
15	15 Goldman Sachs New York	–	-USD 253 k	-51,061	Cerradas
16	16 Eidelman Virant Capital Saint Louis, Missouri	–	-USD 173 k	-35,000	Cerradas
17	17 FNY Investment Advisers New York	–	-USD 2 k	-521	Cerradas
18	18 Bank of America Charlotte, North Carolina	–	+USD 682	+211	Nuevas